Product Information
LAMICTAL ODT 200 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $17.4889 per EA under NDC 00173077702. Its NADAC has been published 655 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173077702
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMOTRIGINEApproval Type
New Drug (NDA)
FDA Application
NDA022251On Market Since
6/5/2009
Pharmacological Classes
Price Statistics
The NADAC for LAMICTAL ODT 200 MG TABLET has been published 655 times since Nov 28, 2013, and over the history we have for it it has risen 118.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.4889 per EA |
|---|---|
| All-time high | $17.5309 (Feb 11, 2026) |
| All-time low | $7.9475 (Dec 18, 2013) |
| 52-week high | $17.5309 |
| 52-week low | $17.4271 |
| Median price | $14.4694 |
| Average price | $14.3030 |
| Largest weekly change | +15.0% (Jan 14, 2015) |
| Weeks tracked | 655 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LAMICTAL ODT 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL ODT 200 MG TABLET, manufactured by GlaxoSmithKline LLC, is $17.4889 per EA (NDC 00173077702), effective Jun 24, 2026.
How has the price of LAMICTAL ODT 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMICTAL ODT 200 MG TABLET has risen 118.6%. It has been tracked across 655 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMICTAL ODT 200 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMICTAL ODT 200 MG TABLET has ranged from a low of $7.9475 (Dec 18, 2013) to a high of $17.5309 (Feb 11, 2026), with a median of $14.4694 per EA.
Are there cheaper alternatives to LAMICTAL ODT 200 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LAMICTAL 200 MG TABLET, is $12.0569 per EA — about 31% below LAMICTAL ODT 200 MG TABLET.
Who manufactures LAMICTAL ODT 200 MG TABLET?
LAMICTAL ODT 200 MG TABLET (NDC 00173077702) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification